Pursuant to Regulation 30 of SEBI Listing Regulations, we would like to inform you that Healthcare Global (Kenya) Private Limited, a step-down subsidiary of the Company has today, i.e., October 05, 2026, entered into a Share Purchase Agreement with Meditec Systems Limited for acquisition of 10 (ten) ordinary shares of Advanced Molecular Imaging Limited held by Meditec, for an aggregate consideration of 42,150 Kenyan Shillings (approximately INR 31,288 as on October 05, 2026).

October 05, 2026 National Stock Exchange of India Limited, BSE Limited, Compliance Department, Compliance Department, Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (East), Mumbai - 400051, Dalal Street, Mumbai - 400001, Maharashtra, India Maharashtra, India Dear Sir/Madam, Subject : Intimation under Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Stock Code : BSE – 539787, NSE – HCG Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we would like to inform that Healthcare Global (Kenya) Private Limited (“HCG Kenya”), a step-down subsidiary of Healthcare Global Enterprises Limited (“Company”), has today, i.e., October 05, 2026, entered into a Share Purchase Agreement (“SPA”) with Meditec Systems Limited (“Meditec”) for acquisition of 10 (Ten) ordinary shares of Advanced Molecular Imaging Limited (“AMIL”) held by Meditec, for an aggregate consideration of 42,150 Kenyan Shillings (approximately INR 31,288 as on October 05, 2026). The consideration payable under the SPA has been paid by HCG Kenya today. Consequent to the acquisition, HCG Kenya’s shareholding in AMIL has increased from 50% to 50.10% of the share capital of AMIL. Accordingly, AMIL, which was an associate of the Company prior to the acquisition, has become a subsidiary of HCG Kenya and, consequently, a step-down subsidiary of the Company. We are enclosing herewith the brief details of the above acquisition, as prescribed under the SEBI Listing Regulations read with the applicable SEBI Master Circular, as Annexure A. We request you to kindly take the above information on record and bring the same to the notice of all concerned. The above information is also available on the website of the Company. Thanking you, For HealthCare Global Enterprises Limited Sunu Manuel Company Secretary & Compliance Officer HealthCare Global Enterprises Limited Reg Off: HCG Towers #8, P. Kalinga Rao Road, Sampangi Ram Nagar, Bengaluru - 560 027, Karnataka, India Corp Off: #3, G-Floor, Tower Block, Unity Buildings Complex, Mission Road, Bengaluru - 560 027, Karnataka, India 91 80 4660 7700 | Email-query@hcgel.com | Website - www.hcgoncology.com | CIN: L15200KA1998PLC023489 Ahmedabad | Bengaluru | Bhavnagar | Chennai | Cuttack | Hubballi | Indore | Jaipur | Kalaburagi | Kenya | Kolkata | Mumbai | Nagpur | Nashik | Ongole | Rajkot | Ranchi | Shimoga | Vadodara | Vijayawada | Vizag Annexure A Relevant details under amended Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read along with the SEBI Master Circular No. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026. Sr. Particulars Details of AMIL 1. Name of the Target Company, details Advanced Molecular Imaging Limited (“AMIL”). AMIL in brief such as size, turnover, etc. is a company incorporated under the laws of Kenya. The Share Capital comprises of 10,000 Ordinary Shares with a face value of 100 Kenyan Shillings per share. Revenue from Operations (FY26): INR 10.96 Crores 2. Whether the acquisition would fall No, the transaction does not fall within the ambit of a within the related party transaction(s) related party transaction. HCG Kenya is a step-down and whether the promoter /promoter subsidiary of the Company and, prior to the present group/ group companies have any acquisition, held 50% of the share capital of AMIL. interest in the entity being acquired? Consequent to the acquisition, its shareholding in AMIL has increased to 50.10%. If yes, nature of interest and details thereof and whether the same is done at "arm’s length" 3. Industry to which the entity being Healthcare – Molecular Imaging / Diagnostic Imaging acquired belongs 4. Objects and impact of acquisition HCG Kenya is an existing shareholder of AMIL. The (including but not limited to, acquisition of the additional 10 Ordinary Shares from disclosure of reasons for acquisition Meditec further consolidates HCG Kenya’s shareholding of target entity, if its business is in AMIL. Consequent to the acquisition, HCG Kenya’s outside the main line of business of shareholding in AMIL has increased from 50% to the listed entity) 50.10%. 5. Brief details of any governmental or No specific governmental or regulatory approvals are regulatory approvals required for the required for this acquisition. acquisition HealthCare Global Enterprises Limited Reg Off: HCG Towers #8, P. Kalinga Rao Road, Sampangi Ram Nagar, Bengaluru - 560 027, Karnataka, India Corp Off: #3, G-Floor, Tower Block, Unity Buildings Complex, Mission Road, Bengaluru - 560 027, Karnataka, India 91 80 4660 7700 | Email-query@hcgel.com | Website - www.hcgoncology.com | CIN: L15200KA1998PLC023489 Ahmedabad | Bengaluru | Bhavnagar | Chennai | Cuttack | Hubballi | Indore | Jaipur | Kalaburagi | Kenya | Kolkata | Mumbai | Nagpur | Nashik | Ongole | Rajkot | Ranchi | Shimoga | Vadodara | Vijayawada | Vizag 6. Indicative time period for completion The execution of the SPA and payment of consideration of the acquisition to Meditec for the acquisition of additional 10 Ordinary Shares has been completed by HCG Kenya on October 05, 2026. 7. Consideration - whether Cash Cash Consideration consideration or share swap or any other form and details of the same 8. Cost of acquisition and/or the price at The 10 Ordinary Shares have been acquired for an which shares are acquired aggregate consideration of 42,150 Kenyan Shillings (approximately INR 31,288 as on October 05, 2026). 9. Percentage of shareholding/ control HCG Kenya has acquired additional 10 (Ten) ordinary acquired and/ or number of shares shares of AMIL, representing approximately 0.10% of its acquired share capital. Consequently, HCG Kenya’s shareholding in AMIL has increased from 50% to 50.10%. 10. Brief background about the entity AMIL is a company incorporated under the laws of Kenya acquired in terms of product/line of and is engaged in Molecular Imaging / Diagnostic and business acquired, date of Imaging. incorporation, history of last 3 years turnover, country in which the Date of incorporation: October 07, 2016. acquired entity has presence and any Country of presence: Kenya. other significant information (in Turnover: brief) Turnover Amount in Amount in INR Kenya Shillings FY ending 156,281,949 109,563,210 December 31, 2025. FY ending Nil Nil December 31, 2024. FY ending Nil Nil December 31, 2023. HealthCare Global Enterprises Limited Reg Off: HCG Towers #8, P. Kalinga Rao Road, Sampangi Ram Nagar, Bengaluru - 560 027, Karnataka, India Corp Off: #3, G-Floor, Tower Block, Unity Buildings Complex, Mission Road, Bengaluru - 560 027, Karnataka, India 91 80 4660 7700 | Email-query@hcgel.com | Website - www.hcgoncology.com | CIN: L15200KA1998PLC023489 Ahmedabad | Bengaluru | Bhavnagar | Chennai | Cuttack | Hubballi | Indore | Jaipur | Kalaburagi | Kenya | Kolkata | Mumbai | Nagpur | Nashik | Ongole | Rajkot | Ranchi | Shimoga | Vadodara | Vijayawada | Vizag